US Executive Officer Management Changes SEC — May 07, 2026

07-05-2026

ITT Inc. announced the departure of CFO Emmanuel Caprais effective May 8, 2026, for personal reasons after nearly 14 years of service, with no disagreements on operations, policies, or practices; he will serve as a business advisor until July 1, 2026. Michael J. Savinelli, age 55 and current Vice President, Treasurer, Chief Tax Officer & Assistant Secretary, was appointed interim CFO effective the same date while a permanent successor is sought. The transition is described as seamless, with Savinelli receiving $300,000 in restricted stock units and a $25,000 monthly cash stipend.

• ·Emmanuel Caprais' departure is not due to any disagreement with company operations, policies, or practices.
• ·Michael J. Savinelli's prior roles: VP & Chief Tax Officer since 2011, Treasurer since 2020; previous experience at Terex, GE Capital, PepsiCo, and Ernst & Young LLP.
• ·Savinelli holds LL.M. in Taxation (NYU), J.D. (Quinnipiac), B.S. in accounting (Fairfield); law licenses in NY and CT, CPA in CT.
• ·No related party transactions for Savinelli under Item 404(a) of Regulation S-K.
• ·Filing signed by Lori B. Marino on May 7, 2026; earliest event date May 2, 2026.

07-05-2026

Target Hospitality Corp. (Nasdaq: TH) announced the appointment of Paul Hohnsbeen as an independent director to its Board of Directors, effective May 5, 2026, with membership on the Nominating and Corporate Governance Committee. Mr. Hohnsbeen brings over three decades of expertise in data centers, real estate development, construction, energy infrastructure, and AI-enabled workflows, particularly from roles at Aligned Data Centers, Equinix, and others. The appointment supports Target's strategic growth in high-value end markets like AI-driven data centers, as stated by CEO Brad Archer.

• ·Mr. Hohnsbeen's career highlights: COO at Aligned Data Centers (since 2022), VP IBX Operations EMEA at Equinix (2016-2021), Director Business Strategy at Laing O’Rourke (2013-2015), Group COO at Global Switch (2010-2012), Executive Program Director at KEO International Consultants (2009-2010), various executive roles at Lehman Brothers (2002-2008), and senior roles at Deutsche Bank, Morgan Stanley, Gregotti Associati International, and Skidmore, Owings & Merrill.
• ·Bachelor of Arts in Architecture from University of California, Berkeley.
• ·Investor contact: Mark Schuck, (832) 702-8009, ir@targethospitality.com

07-05-2026

Ring Energy reported Q1 2026 average daily sales volumes of 19,351 Boe/d and 12,276 Bo/d of oil, meeting guidance midpoints and up 5% and 2% YoY respectively, though down 6% QoQ; revenues reached $73.7 million, up 10% QoQ but down 7% YoY. The company recorded a net loss of $220.6 million driven by a $162.1 million non-cash ceiling test impairment and $77.0 million unrealized derivative loss, offset by Adjusted Net Income of $7.4 million, Adjusted EBITDA of $38.3 million flat QoQ, and $25.9 million net cash from operations for the 26th consecutive positive quarter. LOE of $10.41 per Boe beat guidance by 3%, while Adjusted Free Cash Flow fell 96% QoQ and 97% YoY to $0.2 million.

• ·Sold ~200 Boe/d non-operated NWS assets for $4.5 million (4.5x estimated NTM cash flow).
• ·Borrowings increased $6 million to $426 million from $420 million at Dec 31, 2025; borrowing base $585 million.
• ·Hedged ~72% of 2026 oil sales guidance at $73.27 average and ~73% natural gas at $3.78 average through Dec 2026.
• ·Q2-Q4 2026 guidance: Total oil sales midpoint 12,950-13,300 Bo/d; total Boe/d 20,200-20,600; capex midpoint $32-21 million.
• ·Drilled 5 horizontal wells in Northwest Shelf (91% WI), completed 1 horizontal DUC and 1 vertical in Central Basin Platform (100% WI).

07-05-2026

On May 1, 2026, Luxfer Holdings PLC entered into new or amended Executive Severance and Change in Control Agreements with named executive officers including CEO Andrew Butcher, CFO Stephen Webster, Howard Mead (VP and GM, Luxfer Gas Cylinders – Composite), and Jeffrey Moorefield (VP and GM, Luxfer Magtech). The agreements are substantially consistent with prior arrangements described in the April 30, 2026 proxy statement but include updates to NEO covenants (e.g., omitting non-competition and non-solicitation for some) and expanded definitions of Change in Control Termination for Mead and Moorefield related to divestitures of over 75% of their primary divisions. Full agreements are attached as Exhibits 10.1-10.4.

• ·Agreements impose responsibilities on NEOs during notice periods and require reasonable assistance to the Company.
• ·Change in Control Termination for Mead and Moorefield now includes qualifying terminations following disposition of >75% of Primary Division assets or equity to an unrelated entity.
• ·Description qualified by full text in Exhibits 10.1 (Butcher), 10.2 (Webster), 10.3 (Mead), 10.4 (Moorefield).

07-05-2026

Pagaya Technologies reported Q1 2026 results with GAAP net income of $25 million (up $17 million YoY), Adjusted EBITDA of $94 million (up 18% YoY), total revenue and other income of $318 million (up 10% YoY), and network volume of $2.6 billion (up 9% YoY, or 23% ex-SFR). However, FRLPC margin contracted 19 basis points YoY to 4.6% due to asset mix shifts and tighter pricing, while the company announced CFO Evangelos Perros stepping down effective June 15, succeeded by Jon Dobres. Full-year 2026 guidance was raised, including GAAP net income to $110-$160 million.

• ·Onboarded 4 partners year-to-date across all three asset classes.
• ·Q2 2026 outlook: Network Volume $2.875B-$3.075B; Total Revenue $345M-$365M; Adjusted EBITDA $100M-$115M; GAAP Net Income $25M-$45M.
• ·FY2026 outlook: Network Volume $11.45B-$13B; Total Revenue $1.4B-$1.575B; Adjusted EBITDA $420M-$460M; GAAP Net Income $110M-$160M.

07-05-2026

AudioEye, Inc. announced a leadership evolution effective immediately, with David Moradi assuming roles as Executive Chairman and Chief Product Officer to focus on capital allocation, strategy, and AI initiatives, while Kelly Georgevich becomes Chief Executive Officer, joins the Board, and continues as CFO during the search for a new CFO. The company highlighted strong historical performance since 2019, including revenues nearly quadrupled, adjusted EBITDA margins approaching 30%, 41 straight quarters of sequential revenue growth, and over 127,000 customers. No declines or flat metrics were reported, positioning the company for continued growth and innovation.

• ·AudioEye serves over 127,000 customers including Samsung, Lands' End, and Samsonite.
• ·Solution includes 24/7 accessibility monitoring, automated WCAG issue testing and fixes, expert testing, developer tools, and legal protection.

07-05-2026

Shake Shack Inc. (NYSE: SHAK) announced the appointment of Michelle Hook as Chief Financial Officer, effective May 11, 2026, to lead financial operations including accounting, treasury, FP&A, tax, investor relations, and external reporting. Ms. Hook joins from Portillo’s where she served as CFO since December 2020 and previously spent over 17 years at Domino’s Pizza, Inc. The company operates over 685 locations system-wide, including over 440 in the U.S. and over 245 internationally.

• ·Ms. Hook previously led finance, supply chain, and IT at Portillo’s, helped take it public in 2021.
• ·At Domino’s, Ms. Hook was VP of Finance for global FP&A and investor relations.
• ·Ms. Hook holds an MBA from University of Michigan, B.A. in accounting from Michigan State University, and is a CPA.
• ·Original Shack opened in 2004 in NYC’s Madison Square Park.

07-05-2026

enGene announced updated interim results from the Phase 2 LEGEND pivotal cohort (n=125 BCG-unresponsive NMIBC patients), achieving 54% complete response (CR) rate at any time and 43% at six months, with low progression to muscle-invasive disease (3.2%) and favorable tolerability (55% TRAEs, mostly Grade 1-2; 2.4% discontinuation). However, Kaplan-Meier 12-month CR rate is 25% with median duration of response of 37.3 weeks, below hopes for durability, and recent patients (n=32) showed lower CR rates of 39% at any time and 32% at six months. The company plans FDA engagement for potential BLA filing and presentation at AUA on May 15, 2026.

• ·91% of CRs occurred at first disease assessment
• ·Median DoR: 37.3 weeks (95% CI: 31.6-43.9 weeks)
• ·Of 6-month responders: 37/44 in CR at 9 months; 13/22 at 12 months
• ·Most common TRAEs: fatigue (22%), dysuria (14%), micturition urgency (12%), pollakiuria (12%), bladder spasm (11%)
• ·Webcast held May 7, 2026 at 8:00 a.m. ET; FDA manufacturing validation batches completed; SAP submitted

07-05-2026

On May 6, 2026, at Rogers Corporation's annual shareholder meeting, all nine director nominees were elected with strong support exceeding 16 million 'For' votes each and minimal 'Withheld' votes. Shareholders also ratified PricewaterhouseCoopers LLP as the independent auditors for the fiscal year ending December 31, 2026 (16,735,256 For), approved the 2025 named executive officer compensation on an advisory basis (15,944,114 For), and approved the 2026 Employee Stock Purchase Plan authorizing 200,000 shares plus remaining shares from the prior plan. No proposals failed, with opposition below 3% in all cases.

• ·2026 ESPP replaces prior plan for offering periods starting June 16, 2026 (prior plan ends June 15, 2026)
• ·Proxy statement filed March 24, 2026
• ·Detailed voting: 2026 ESPP - 16,315,597 For, 34,691 Against, 32,795 Abstain

07-05-2026

Commerce Bancshares, Inc. announced that Mr. Benjamin F. Rassieur, III retired from its Board of Directors effective May 7, 2026, due to the company's mandatory retirement requirements. He had served as a Board member since 1997 and was a member and former chairman of the Audit and Risk Committee. No successor was mentioned in the filing.

07-05-2026

Power Integrations Inc filed an 8-K on 2026-05-07 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), results of operations and financial condition under Item 2.02, and financial statements and exhibits under Item 9.01. No specific details on the officer involved, nature of the change, reasons, financial metrics, or performance comparisons are disclosed. Sector is not specified.

• ·AccNo: 0000833640-26-000076
• ·Filing size: 781 KB
• ·Event date: 2026-05-07

07-05-2026

Arcturus Therapeutics reported Q1 2026 financial results with total revenue of $2.1 million, down $27.3 million or 93% YoY due to lower CSL collaboration and pivot to rare diseases, while operating expenses decreased 33% YoY to $31.0 million; however, net loss widened to $27.0 million from $14.1 million YoY. Positively, the company initiated enrollment earlier than expected for the ARCT-032 12-week Phase 2 CF study (up to 20 Class I participants), received FDA Type C meeting guidance for pediatric ARCT-810 OTC program with EOP2 meeting planned H2 2026, appointed new CMO Alan H. Cohen and CFO Dennis M. Mulroy, and maintained $213.4 million in cash providing runway beyond Q2 2028.

• ·Cash runway extends beyond second quarter of 2028.
• ·ARCT-032 Phase 2 study monitors 10 mg dosing over 12 weeks for safety, ppFEV1, LCI, quality-of-life measures, and HRCT imaging.
• ·Meiji preparing KOSTAIVE® for 2026/2027 season with 2-dose vial.
• ·Earnings call held May 7, 2026 at 4:30 p.m. ET.

07-05-2026

Telos Corporation held its annual stockholder meeting on May 7, 2026, where seven directors were elected by plurality vote, PricewaterhouseCoopers LLP was ratified as independent auditors for FY 2026, Amendment No. 2 to the 2016 Omnibus Long-Term Incentive Plan was approved to increase available shares by 5,380,000, and the say-on-pay proposal received majority approval. All proposals passed with strong support, though the incentive plan had notable opposition (5,837,559 against) and broker non-votes (7,719,872). Director elections saw varying levels of support, with David Borland receiving the lowest FOR votes at 44,173,074 amid 10,697,281 withheld.

• ·Director election votes - WITHHELD: John B. Wood (2,331,230), David Borland (10,697,281), Maj. John W. Maluda (2,295,302), Bonnie Carroll (2,830,510), Derrick D. Dockery (2,773,307), Brad Jacobs (1,965,556), Fredrick D. Schaufeld (1,639,801)
• ·Auditor ratification: AGAINST 121,460, ABSTAIN 16,880
• ·Incentive plan: AGAINST 5,837,559, ABSTAIN 23,418
• ·Say-on-pay: AGAINST 1,649,451, ABSTAIN 28,207

07-05-2026

At the 2026 Annual Meeting of Shareholders on May 7, 2026, Steven L. Waechter's term as Class III director ended due to the Company's Corporate Governance Principles requiring directors to be 75 or younger at nomination, with no disagreements on operations; the Board size reduced from 10 to 9 members. Shareholders elected Melvin F. Parker, Ross S. Niebergall, and Jeremy C. Wensinger as Class III Directors for three-year terms, ratified RSM US LLP as independent auditors for fiscal year 2026, and approved named executive officer compensation for fiscal year 2025 on an advisory basis, all with majority support.

• ·Gerard A. Fasano to replace Steven L. Waechter on Compensation and Human Capital Committee effective May 8, 2026.
• ·Nicole B. Theophilus to replace Steven L. Waechter on Nominating and Governance Committee effective May 8, 2026.
• ·Class III Directors elected for terms expiring at 2029 Annual Meeting.
• ·One Class III director position eliminated.

07-05-2026

Perdoceo Education Corporation reported Q1 2026 revenue of $221.7 million, up 4.1% YoY from $213.0 million, with strong growth at USAHS (+9.8%) and CTU (+4.0%), but AIUS revenue increased only 0.4% and enrollments declined 2.2%. Operating income rose 22.0% to $63.1 million, adjusted operating income increased 14.1% to $72.5 million, and diluted EPS grew 30.8% to $0.85 from $0.65. Total student enrollments increased 1.1% to 48,740, supported by CTU (+1.9%) and USAHS (+3.1%).

• ·Board declared quarterly dividend of $0.15 per share, payable June 12, 2026 to holders as of June 1, 2026.
• ·Net cash provided by operating activities $69.4 million in Q1 2026, up 6.5% YoY; capital expenditures $1.7 million, up 0.2% YoY.
• ·Q2 2026 outlook: Adjusted EPS $0.79-$0.80; FY 2026 outlook: Adjusted EPS $3.05-$3.16.

07-05-2026

On May 1, 2026, Adam Appleby informed Conduent Inc. that he is resigning from his position as Executive Vice President, Public Sector Solutions, effective May 19, 2026, to pursue other professional endeavors. He will remain through May 19 to ensure a smooth transition. The resignation is not due to any disagreement with the company's financial reporting, operations, policies, practices, or any other matter.

07-05-2026

On May 6, 2026, SenesTech, Inc. appointed Michael Edell as President and Chief Executive Officer, succeeding Joel L. Fruendt, and also appointed him as a Class III director. The appointment includes an annual base salary of $360,000, a target annual incentive bonus of 60% of base salary (pro-rated for 2026 from April 1), and an option to purchase 5.0% of the Company's outstanding common stock vesting over three years from May 1, 2026, subject to stockholder approval of increased shares under the 2018 Equity Incentive Plan. Concurrently, Jamie Bechtel's role as Interim Executive Chair concluded.

• ·Option vests 1/12th quarterly over three years commencing May 1, 2026, subject to continuous service and stockholder approval of increased shares under the 2018 Equity Incentive Plan.
• ·Severance upon termination without Cause or resignation for Good Reason: up to 12 months base salary continuation, healthcare reimbursement, full Option vesting, and pro-rated bonus based on actual performance.
• ·Mr. Edell previously served as Interim COO from October 2025 to May 1, 2026; no family relationships or special arrangements for his appointment.

07-05-2026

Mastercard Incorporated announced on May 5, 2026, that Sandra Arkell, the Company's Corporate Controller and principal accounting officer, will assume the role of Chief Audit Executive effective August 3, 2026, stepping down from her current position. Chris Mullett, age 52, who joined the Company in November 2017 and has served as Chief Financial Officer, Europe since May 2023, will succeed her as Corporate Controller and principal accounting officer on the same date. Mr. Mullett will receive a base salary and benefits consistent with his position and Company plans.

• ·Chris Mullett previously served as Chief Financial Officer, Technology and Regional Controller, Asia Pacific.
• ·Mr. Mullett is eligible for the Mastercard International Annual Incentive Compensation Plan and Mastercard International Change-in-Control Severance Plan.
• ·Filing signed by Gina Accordino on May 7, 2026.

07-05-2026

Amtech Systems, Inc. appointed Guy Shechter, age 57, as President and Chief Operating Officer effective May 19, 2026, reporting to CEO Robert C. Daigle. Shechter has prior leadership experience at Yield Engineering Systems (2021-2026) and Veeco Instruments (2007-2020). Compensation includes an annual base salary of $400,000, target bonus of 50% of base salary, 50,000 stock options, $10,000 monthly payments for first six months, and up to $25,000 relocation support, with severance provisions for change in control or termination without cause.

• ·Offer letter dated March 9, 2026; at-will employment
• ·Stock options subject to Board approval; vest in three equal annual installments
• ·No arrangements, family relationships, or material interests under Item 404(a) of Regulation S-K
• ·Board approval date: May 5, 2026; filing date: May 7, 2026

07-05-2026

Century Casinos Inc. (/CO/) filed an 8-K on 2026-05-07 disclosing an officer change event under Item 5.02, covering departures of directors or certain officers, elections of directors, appointments of certain officers, and compensatory arrangements. Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for change, or quantitative data are provided.

• ·AccNo: 0000911147-26-000018
• ·Event date: May 07, 2026
• ·Sector: not specified

07-05-2026

On May 4, 2026, the Board of Trustees of New Mountain Private Credit Fund appointed Laura C. Holson as interim Chief Financial Officer and Treasurer, effective May 29, 2026, until a permanent successor is identified. Ms. Holson, age 40, continues in her role as Chief Operating Officer of the Company and serves as a Managing Director at New Mountain Capital, L.L.C., where she has worked since 2009. The investment adviser confirmed adequate staffing support, with no arrangements, family relationships, or reportable transactions involved.

• ·Ms. Holson has been Chief Operating Officer of New Mountain Capital’s credit platform since January 2022 and of the Company since February 2022.
• ·Previously held roles including Head of Capital Markets at New Mountain Capital; member of credit team for over 13 years.
• ·Registrant is an emerging growth company.

07-05-2026

A10 Networks, Inc. terminated Sheen Khoury as Executive Vice President, Worldwide Sales and Marketing, effective immediately on April 27, 2026. The company executed a Separation Agreement on May 2, 2026, providing for accelerated vesting of 11,667 restricted stock units and 21,385 performance-based restricted stock units under the 2023 Stock Incentive Plan upon effectiveness, with no other compensation or benefits provided.

• ·Separation Agreement effective on the eighth day after Mr. Khoury signed, provided it is not revoked by either party.
• ·Filing date: May 07, 2026; Date of earliest event: May 02, 2026.

07-05-2026

On May 4, 2026, the Board of Directors of New Mountain Guardian IV BDC, L.L.C. appointed Laura C. Holson as interim Chief Financial Officer and Treasurer, effective May 29, 2026, until a permanent successor is identified. Ms. Holson, age 40 and current Chief Operating Officer, joined New Mountain Capital in 2009, serves as a Managing Director, and previously held the interim CFO role from March 2023 to November 2023. The appointment involves no related arrangements, family relationships, or reportable transactions under Item 404(a) of Regulation S-K.

• ·Ms. Holson has been Chief Operating Officer of the Company since February 2022 and of New Mountain Capital’s credit platform since January 2022.
• ·Ms. Holson previously served as Head of Capital Markets at New Mountain Capital and has been on its credit team for over 13 years.
• ·The Company’s investment adviser states that its management team is adequately staffed with support from New Mountain Capital.

07-05-2026

Post Holdings reported second quarter fiscal 2026 net sales of $2,042.9 million, up 4.7% YoY including $152.3 million from acquisitions, with operating profit rising 16.3% to $211.9 million and Adjusted EBITDA increasing 14.0% to $395.0 million; the company affirmed its FY2026 Adjusted EBITDA outlook of $1,550-$1,580 million. However, excluding acquisitions, Post Consumer Brands volumes declined 10.0% (pet food -14.1%, cereal/granola -3.5%), resulting in a 1.8% drop in segment Adjusted EBITDA to $200.2 million, while Weetabix volumes fell 2.6%. Foodservice and Refrigerated Retail segments showed strong growth, with Foodservice Adjusted EBITDA up 47.9% and Refrigerated Retail up 17.6%.

• ·Interest expense, net increased to $105.7 million in Q2 FY2026 from $87.0 million YoY.
• ·Q2 diluted EPS $1.56 vs $1.03 prior year; Adjusted diluted EPS $1.94 vs $1.41.
• ·Board approved new $600 million share repurchase authorization on May 5, 2026.
• ·Acquired 8th Avenue on July 1, 2025; sold its pasta business December 1, 2025; acquired PPI March 3, 2025.

07-05-2026

Danaher Corp /DE/ filed an 8-K on 2026-05-07 disclosing under Item 5.02 departures of directors or certain officers, elections or appointments of directors or officers, and compensatory arrangements of certain officers. Item 5.07 reports submission of matters to a vote of security holders, while Item 9.01 includes financial statements and exhibits. No specific details such as names, positions affected, reasons for changes, vote outcomes, or quantitative metrics are disclosed.

07-05-2026

STERIS plc filed an 8-K on 2026-05-07 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Key details such as the affected position (e.g., CEO, CFO), whether it is an appointment or resignation, reason for the change, effective date, and any internal/external aspects are NOT_DISCLOSED. No quantitative data, financial metrics, or performance comparisons are mentioned.

07-05-2026

Berkshire Hathaway reported Q1 2026 operating earnings of $11,346 million, up 18% YoY from $9,641 million, bolstered by insurance underwriting (+29% to $1,717 million), BNSF (+13% to $1,377 million), and manufacturing/service/retailing (+5% to $3,199 million). However, insurance investment income declined 7% to $2,679 million while Berkshire Hathaway Energy grew only 2% to $1,114 million. Net earnings attributable to shareholders rose sharply to $10,106 million from $4,603 million, reflecting reduced investment losses of $1.2 billion versus $5.0 billion.

• ·Investment gains (losses) after-tax: $(1,240) million in Q1 2026 vs $(5,038) million in Q1 2025
• ·Net earnings per average equivalent Class A share: $7,027 in Q1 2026 vs $3,200 in Q1 2025
• ·Other operating earnings includes $249 million FX gains in Q1 2026 vs $713 million FX losses in Q1 2025, plus $967 million interest/dividend income
• ·Unrealized losses on equity securities approx. $7.0 billion after-tax Q1 2026 and $7.4 billion Q1 2025; realized gains $5.8 billion Q1 2026 and $2.4 billion Q1 2025

07-05-2026

IN8BIO, INC. filed an 8-K on 2026-05-07 disclosing results of operations and financial condition under Item 2.02, an officer change or related matters under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), and submission of matters to a vote of security holders under Item 5.07. No specific details on the officer position, appointment/resignation status, reasons, financial metrics, vote outcomes, or other quantitative data are disclosed in the provided filing summary.

07-05-2026

On May 4, 2026, the Board of Directors of NMF SLF I, Inc. appointed Laura C. Holson as interim Chief Financial Officer and Treasurer, effective May 29, 2026, until a permanent successor is identified. Ms. Holson, age 40 and currently serving as the Company's Chief Operating Officer and a Managing Director at New Mountain Capital, will continue in her COO role. The Company's investment adviser believes the management team is adequately staffed with support from New Mountain Capital.

• ·Ms. Holson joined New Mountain Capital in 2009; COO of credit platform since January 2022 and of the Company since February 2022.
• ·Previously served as interim CFO and Treasurer from March 2023 to November 2023.
• ·No arrangement or understanding with any other person for appointment; no family relationships with directors/officers; no reportable transactions under Item 404(a) of Regulation S-K.

07-05-2026

Pediatrix Medical Group, Inc. held its 2026 Annual Shareholders’ Meeting on May 7, 2026, where shareholders elected all nine director nominees, ratified PricewaterhouseCoopers LLP as the independent auditor for fiscal 2026, approved executive compensation on an advisory basis, and approved the Second Amended and Restated 2008 Incentive Compensation Plan increasing available shares by 8,000,000. Of 83,072,104 shares outstanding, 77,330,139 were represented at the meeting. All proposals passed, though director John M. Starcher, Jr. received significant opposition with 25,909,618 votes against compared to 46,296,745 for.

• ·Proposal 1 (Director Elections): Votes ranged from 46,296,745 For (John M. Starcher, Jr.) to 71,922,039 For (Kurt D. Newman, M.D.), with consistent 5,095,808 broker non-votes.
• ·Proposal 2 (Auditor Ratification): 75,519,473 For, 1,794,278 Against, 16,388 Abstain.
• ·Proposal 3 (Executive Compensation): 70,257,832 For, 1,960,931 Against, 15,568 Abstain.
• ·Proposal 4 (Incentive Plan): 65,912,243 For, 6,303,675 Against, 18,413 Abstain.

07-05-2026

At the 2026 Annual Meeting on May 7, 2026, Peabody Energy Corporation stockholders elected all ten director nominees (Bob Malone, M. Katherine Banks, Andrea E. Bertone, William H. Champion, Nicholas J. Chirekos, Stephen E. Gorman, James C. Grech, Georganne M. Hodges, Joe W. Laymon, and Clayton D. Walker) for one-year terms, approved the 2026 Incentive Plan, gave advisory approval to named executive officers' compensation, and ratified Ernst & Young LLP as the independent auditor for 2026. Following re-election, Robert A. Malone (Chair of the Board) offered resignation effective at the 2027 Annual Meeting per Corporate Governance Guidelines due to reaching age 75, but the Board rejected it and authorized his continuation for one additional year subject to re-election; the Board also approved amendments creating a Vice Chair role post-2027 meeting.

• ·Broker non-votes: 15,906,733 across director proposals
• ·Executive compensation advisory vote: 85,941,173 FOR, 1,477,363 AGAINST, 352,437 ABSTAIN
• ·2026 Incentive Plan vote: 86,289,993 FOR, 1,245,353 AGAINST, 235,627 ABSTAIN
• ·Auditor ratification: 102,341,512 FOR, 1,249,591 AGAINST, 86,603 ABSTAIN (no broker non-votes)

07-05-2026

On May 4, 2026, the Board of Directors of New Mountain Guardian IV Income Fund, L.L.C. appointed Laura C. Holson as interim Chief Financial Officer and Treasurer, effective May 29, 2026, until a permanent successor is identified. Ms. Holson, age 40 and currently Chief Operating Officer of the Company and a Managing Director at New Mountain Capital, L.L.C., will continue in her COO role while previously having served in this interim CFO position from May 2023 to November 2023. The appointment involves no arrangements with other persons, family relationships with directors or officers, or reportable transactions under Item 404(a) of Regulation S-K.

• ·Ms. Holson joined New Mountain Capital in 2009 and has been on the credit team for over 13 years.
• ·Chief Operating Officer of New Mountain Capital’s credit platform since January 2022.
• ·Chief Operating Officer of the Company since February 2022.
• ·The Company’s investment adviser believes its management team is adequately staffed with support from New Mountain Capital.

07-05-2026

On May 6, 2026, Brown & Brown, Inc. held its Annual Meeting of Shareholders, where 14 directors were elected with strong support (ranging from 73% to 99% votes for), Deloitte & Touche LLP was ratified as auditors (290M for vs 16M against), executive compensation was approved on an advisory basis (241M for vs 42M against), and an amendment to the 2019 Stock Incentive Plan was approved to add 6,900,000 shares. Quorum was met with 306,507,079 shares voted, representing 90.27% of 339,559,191 outstanding shares. All proposals passed, though say-on-pay saw notable opposition at 42,472,512 votes against.

• ·Auditor ratification: 290,036,120 for, 16,369,254 against, 101,705 abstentions
• ·Say-on-pay advisory vote: 240,765,556 for, 42,472,512 against, 1,046,377 abstentions, 22,222,634 broker non-votes
• ·SIP amendment: 281,520,155 for, 2,432,780 against, 331,512 abstentions, 22,222,632 broker non-votes
• ·H. Palmer Proctor, Jr. received lowest director support at 259,499,982 for (73.7% of voted shares excluding broker non-votes)

07-05-2026

Assertio Holdings, Inc. held its 2026 Annual Meeting of Stockholders on May 5, 2026, where stockholders elected six directors to the Board (Heather L. Mason, Sravan K. Emany, Sigurd C. Kirk, William T. McKee, Mark L. Reisenauer, and David M. Stark) with vote support ranging from approximately 71-78% for nominees. Stockholders also approved an amendment to the 2014 Omnibus Incentive Plan increasing available shares by 400,000 (71% for vs. 25% against), advisory approval of named executive officer compensation (77% for vs. 20% against), and ratification of Grant Thornton LLP as auditor for FY 2026 (over 85% for). All proposals passed, though director elections and incentive plan saw notable opposition levels of 22-29%.

• ·Proposal 1 director votes: Heather L. Mason (1,760,660 For, 488,116 Against, 25,397 Abstain, 1,802,006 Broker Non-Votes); Sravan K. Emany (1,757,938 For, 490,430 Against, 25,803 Abstain, 1,802,008 Broker Non-Votes); Sigurd C. Kirk (1,748,914 For, 499,041 Against, 26,216 Abstain, 1,802,008 Broker Non-Votes); William T. McKee (1,751,923 For, 496,448 Against, 25,801 Abstain, 1,802,007 Broker Non-Votes); Mark L. Reisenauer (1,783,789 For, 463,495 Against, 26,887 Abstain, 1,802,008 Broker Non-Votes); David M. Stark (1,767,339 For, 480,127 Against, 26,705 Abstain, 1,802,008 Broker Non-Votes)
• ·Proposal 2: 1,613,296 For, 578,470 Against, 82,404 Abstain, 1,802,009 Broker Non-Votes
• ·Proposal 3: 1,739,652 For, 451,308 Against, 83,209 Abstain, 1,802,010 Broker Non-Votes
• ·Proposal 4: 3,577,437 For, 289,020 Against, 209,722 Abstain, 0 Broker Non-Votes

07-05-2026

Six Flags Entertainment Corporation announced leadership transitions to strengthen commercial, marketing, legal, and finance capabilities, including the appointment of Amy Martin Ziegenfuss as Chief Marketing Officer and Christopher Bennett as Chief Legal and Compliance Officer effective June 3, 2026, alongside the promotion of Chris Meyering to SVP, Commercial. However, Christian Dieckmann departed as CMO effective May 2, 2026, Brian Nurse will depart as Chief Legal and Compliance Officer effective May 8, 2026, and Brian Witherow will step down as CFO effective May 8, 2026, with Dave Hoffman serving as Interim Finance Lead until a successor is named.

• ·Christian Dieckmann departed effective May 2, 2026.
• ·Brian Nurse and Brian Witherow depart effective May 8, 2026.
• ·Q1 2026 financial results announced in separate news release; earnings call on May 7, 2026 at 8:00 a.m. ET.
• ·Amy Martin Ziegenfuss previously CMO at Carnival Cruise Line and SVP Global Enterprise & Brand Marketing at Hilton.
• ·Christopher Bennett previously Chief Administrative Officer, General Counsel, and Secretary at Interstate Hotels & Resorts.

07-05-2026

Tonix Pharmaceuticals Holding Corp. held its annual shareholder meeting on May 7, 2026, where nine directors were elected with approximately 3.2 million votes for each amid 470,000-575,000 withheld votes and 3.5 million broker non-votes; PricewaterhouseCoopers LLP was ratified as auditors with strong support (6,910,516 for). Shareholders also approved authorization for reverse stock splits (1:2 to 1:250) at 4,400,765 for versus 2,826,586 against, and the 2026 Stock Incentive Plan at 2,019,646 for versus 1,624,412 against, both with 3.5 million broker non-votes on the latter. Participation represented 7,267,759 shares or 54.22% of outstanding shares as of the March 19, 2026 record date.

• ·Proxy statement filed March 30, 2026, details proposals.
• ·Reverse stock split authorization valid for two years from May 7, 2026.
• ·Annual meeting record date: March 19, 2026.

07-05-2026

Nature’s Sunshine Products reported Q1 2026 net sales up 9% to $122.9 million across all regions, with gross profit margin expanding 116 basis points to 73.2% and Adjusted EBITDA surging 33% to $14.6 million. GAAP net income rose to $5.1 million or $0.29 per diluted share from $4.7 million or $0.25. However, net cash used in operating activities was $1.8 million versus $2.6 million provided prior year, other expense swung to a $1.4 million loss from $0.9 million gain due to FX losses, and cash decreased to $87.6 million.

• ·Volume incentives 30.0% of net sales vs 30.8% prior year.
• ·SG&A $43.5 million or 35.4% of net sales vs $40.6 million or 35.8% prior.
• ·Operating income $9.5 million or 7.8% of net sales vs $6.2 million or 5.4%.
• ·No net income attributable to NSP China in Q1 2026 vs $0.7 million prior due to December 2025 purchase of noncontrolling interests.
• ·Company had zero debt as of March 31, 2026.
• ·Conference call held May 7, 2026 at 5:00 p.m. ET.

07-05-2026

Protolabs announced the appointment of Bernardo Parlange as the newly created Chief Commercial Officer effective May 18, 2026, to oversee global commercial strategy, sales, marketing, and customer success amid its growth phase. Separately, Chief Operations Officer Mike Kenison plans to retire effective July 1, 2026, after nearly two decades of leadership that expanded operations to nine global factories and more than 1 million sq. ft. of manufacturing space. The changes aim to strengthen leadership for accelerating revenue, innovation, and efficiency.

• ·Parlange has more than 20 years of B2B industrial commercial experience, including Senior Vice President of Sales & Marketing at Fortrex, 14 years at Ecolab, and 10 years at ZF Group.
• ·Kenison joined Protolabs in 2006 and held multiple senior operational roles.

07-05-2026

PROG Holdings, Inc. (NYSE:PRG) announced that its Board of Directors named Steve Michaels, President and CEO, as the new Chairman of the Board, succeeding Ray Robinson, who has been appointed Lead Independent Director. The leadership transition is praised for Michaels' strategic vision, strong financial performance delivery, and management team building. No financial metrics or impacts were disclosed in the filing.

• ·Filing Date: May 07, 2026
• ·Headquartered in Salt Lake City, UT
• ·Investor contact: john.baugh@progleasing.com

07-05-2026

At its 2026 annual stockholder meeting on May 7, 2026, Natural Health Trends Corp. shareholders elected Randall A. Mason, Chris T. Sharng, Ellen Sun, and Ching C. Wong as directors until the next annual meeting, approved the 2026 Equity Incentive Plan authorizing up to 1,100,000 shares of common stock for awards, and ratified CBIZ CPAs P.C. as independent auditors for the fiscal year ending December 31, 2026. All proposals passed, though Ching C. Wong received significantly higher withheld votes (778,843) compared to the others (around 89,000 each), indicating relatively weaker support for that nominee. Voter turnout was 58.1%, with 4,982,843 of 8,577,848 entitled shares represented.

• ·Director votes - Randall A. Mason: 2,892,636 For, 89,665 Withheld; Chris T. Sharng: 2,892,546 For, 89,755 Withheld; Ellen Sun: 2,892,763 For, 89,538 Withheld; Ching C. Wong: 2,203,458 For, 778,843 Withheld.
• ·2026 Plan approval: 2,838,885 For, 118,255 Against, 25,161 Abstentions.
• ·Auditor ratification: 4,851,540 For, 115,114 Against, 16,189 Abstentions.
• ·Board adopted 2026 Plan on March 19, 2026; Proxy Statement filed March 24, 2026.